Impact of Age on Poly(ADP-Ribose) Polymerase Inhibitor (PARPi)-Induced Lymphopenia: A Scoping Review of the Literature and Internal Analysis of a Retrospective Database

BACKGROUND: Poly(ADP-ribose) polymerase inhibitors (PARPi) are increasingly used in oncology; their hematological toxicities affect classically red, platelet and neutrophil lineages, but some opportunistic infections have been reported concomitantly to deep lymphopenias. OBJECTIVE: This study was de...

Descripción completa

Detalles Bibliográficos
Autores principales: Antherieu, Gabriel, Heiblig, Maël, Freyer, Gilles, Ghesquieres, Hervé, Falandry, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118227/
https://www.ncbi.nlm.nih.gov/pubmed/37081248
http://dx.doi.org/10.1007/s40266-023-01023-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118227/
https://www.ncbi.nlm.nih.gov/pubmed/37081248
http://dx.doi.org/10.1007/s40266-023-01023-7

Ejemplares similares